NCT07215026View on ClinicalTrials.gov

Understanding Non-small Cell Lung Cancer Patient Characteristics, Treatment Patterns and Outcomes

Not yet recruitingOBSERVATIONAL

Enrollment

800

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Non-small Cell Lung Cancer

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY